|
Originally published In Press as doi:10.1194/jlr.M600529-JLR200 on January 24, 2007
Journal of Lipid Research, Vol. 48, 944-951, April 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology
| Patient-Oriented Research |
Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7 -hydroxy-3-oxo-4-cholestenoic acid
Steve Meaney1,*,
Maura Heverin1,*,
Ute Panzenboeck ,
Lena Ekström ,
Magnus Axelsson**,
Ulla Andersson*,
Ulf Diczfalusy*,
Irina Pikuleva ,
John Wahren ,
Wolfgang Sattler*** and
Ingemar Björkhem2,*
* Division of Clinical Chemistry, Karolinska University Hospital, Huddinge, Sweden
Division of Clinical Pharmacology, Karolinska University Hospital, Huddinge, Sweden
** Division of Clinical Chemistry, Karolinska University Hospital, Solna, Sweden
 Division of Surgical Sciences, Karolinska University Hospital, Solna, Sweden
 Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX
Institute of Pathophysiology, Medical University Graz, Graz, Austria
*** Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University Graz, Graz, Austria
Published, JLR Papers in Press, January 24, 2007.
1 S. Meaney and M. Heverin contributed equally to this work.
2 To whom correspondence should be addressed. e-mail: ingemar.bjorkhem{at}karolinska.se
ABSTRACT
Recently, we demonstrated a net blood-to-brain passage of the oxysterol 27-hydroxycholesterol corresponding to 45 mg/day. As the steady-state levels of this sterol are only 12 µg/g brain tissue, we hypothesized that it is metabolized and subsequently eliminated from the brain. To explore this concept, we first measured the capacity of in vitro systems representing the major cell populations found in the brain to metabolize 27-hydroxycholesterol. We show here that 27-hydroxycholesterol is metabolized into the known C27 steroidal acid 7 -hydroxy-3-oxo-4-cholestenoic acid by neuronal cell models only. Using an in vitro model of the blood-brain barrier, we demonstrate that 7 -hydroxy-3-oxo-4-cholestenoic acid is efficiently transferred across monolayers of primary brain microvascular endothelial cells. Finally, we measured the concentration of 7 -hydroxy-3-oxo-4-cholestenoic acid in plasma from the internal jugular vein and brachial artery of healthy volunteers. Calculation of the arteriovenous concentration difference revealed a significant in vivo flux of this steroid from the brain into the circulation in human. Together, these studies identify a novel metabolic route for the elimination of 27-hydroxylated sterols from the brain. Given the emerging connections between cholesterol and neurodegeneration, this pathway may be of importance for the development of these conditions.
Supplementary key words brain cholesterol homeostasis 27-hydroxycholesterol CYP7B1 CYP27

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Schule, T. Siddique, H.-X. Deng, Y. Yang, S. Donkervoort, M. Hansson, R. E. Madrid, N. Siddique, L. Schols, and I. Bjorkhem
Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis
J. Lipid Res.,
April 1, 2010;
51(4):
819 - 823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ogundare, S. Theofilopoulos, A. Lockhart, L. J. Hall, E. Arenas, J. Sjovall, A. G. Brenton, Y. Wang, and W. J. Griffiths
Cerebrospinal Fluid Steroidomics: Are Bioactive Bile Acids Present in Brain?
J. Biol. Chem.,
February 12, 2010;
285(7):
4666 - 4679.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|